Abstract:Purpose Dopamine transporter (DAT) is a promising target for positron emission tomography (PET) imaging of many neuropsychiatric diseases. 18 F-labelled N-alkyl tropane analogues were reported to be useful PET radioligands for DAT. However, the drawback of 18 F-labelled tropane analogues is that N -alkyl on tropane is easily metabolized in vivo , which interferes with brain imaging. To develop a more in vivo stable DAT-targeted PET radioligand with high DAT affinity and specificity, in this study, we synthesized and compared a series of 18 F-labelled novel deuterated N-fluoropropyl tropane derivatives [ 18 F] 4a-e for DAT tracing. Procedures Five deuterated N-fluoropropyl-d 6 tropane derivatives ( 4a-e ) and corresponding non-deuterated compounds ( 6a-e ) were synthesized, and their semi-inhibitory concentrations (IC 50 ) were measured by competitive binding assay. The radioligands [ 18 F] 4a-e and [ 18 F] 6a-e were obtained by two-step one-pot radio-labelling reactions. The selectivity and specificity of these radioligands were evaluated by cellular uptake and microPET in normal rats. [ 18 F] 4e was selected for further investigation with microPET of the PD model, autoradiography and biodistribution experiments and compared with its non-deuterated [ 18 F] 6e . Finally, in vivo metabolic stability was analyzed by radio-HPLC. Results Ten tropane compounds had high DAT affinity (IC 50 = 2–21 nM), in which FP-CIT-d 6 ( 4e ) had the lowest IC 50 value of 2.7 nM. Radiolabelled [ 18 F] 4a-e and [ 18 F] 6a-e were obtained with radiochemical yields ranging from 10.6 ± 2.8% to 35.1 ± 5.4% with molar activities >20 GBq/μmol and the radiochemical purities >99%. [ 18 F] 4e showed the highest cell uptake (12%) and CFT inhibition efficacy (∼72%) among [ 18 F] 4a-e . MicroPET results showed [ 18 F] 4e has the highest target to non-target ratio (striatum/cerebellum). Therefore, [ 18 F] 4e was then selected for further biological evaluation. Ex vivo autoradiography experiment confirmed high specific binding of [ 18 F] 4e towards DAT. Biodistribution results indicated that [ 18 F] 4e has a higher striatum/cerebellum value than [ 18 F]FP-CIT ([ 18 F] 6e ) at 30–120 min. Furthermore, in vivo metabolism studies in rats revealed improved stability of [ 18 F] 4e as compared with that of [ 18 F] 6e . Conclusions The new probe [ 18 F] 4e is a promising candidate with good DAT affinity, specificity and metabolic stability for PET imaging, and might provide reliable diagnosis, treatment and prognostic detection of DAT-related neuropsychiatric diseases.

一种新的阿片受体显像剂^125I-7α-O-碘烷-特培洛菲的制备及生物学评价

Radiosynthesis and evaluation of acetamidobenzoxazolone based radioligand [C-11]N '-MPB for visualization of 18 kDa TSPO in brain

preparation of amyloid-beta imaging agent 11C-6-OH-BTA-1

Development and Preliminary Evaluation of an Aryl 18F-Labeled PET Tracer for Imaging PDE10A

Radiosynthesis and Evaluation of 4-(6-[18f]fluoro-4-(5-isopropoxy-1h-indazol-3-yl)pyridin-2-yl)morpholine As a Novel Radiotracer Candidate Targeting Leucine-Rich Repeat Kinase 2.

Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold

Synthesis and Biological Evaluation of ~(11)C-DPOD for PET Imaging Agent of Amyloid-b in Mouse Brain

Synthesis and Evaluation of [(18)F]-Fluoromethyl Triphenylphosphonium Cation As a Novel Mitochondria-Specific Positron Emission Tomography Tracer.

P2X7 receptor-specific radioligand 18F-FTTM for atherosclerotic plaque PET imaging

Synthesis, pharmacology and preclinical evaluation of 11C-labeled 1,3-dihydro-2H-benzo[d]imidazole-2-ones for imaging γ8-dependent transmembrane AMPA receptor regulatory protein

Synthesis of K+ channel radioligand [ F]5-methyl-3-fluoro-4-aminopyridine and PET imaging in mice

Synthesis and Evaluation of 18F-Labeled Phenylpiperazine-like Dopamine D3 Receptor Radioligands for Positron Emission Tomography Imaging

Radiosynthesis and Preclinical Evaluation of [18F]F-DPA, A Novel Pyrazolo[1,5a]pyrimidine Acetamide TSPO Radioligand, in Healthy Sprague Dawley Rats

In Vivo Characterization of Two 18F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains.

Studies towards the development of a PET radiotracer for imaging of the P2Y1 receptors in the brain: synthesis, 18F-labeling and preliminary biological evaluation

Synthesis and biological evaluation of 18 F-labelled deuterated tropane derivatives as dopamine transporter probes

P2X7 Receptor-Specific Radioligand 18 F-FTTM for Atherosclerotic Plaque PET Imaging

Preparation of Radioiodinated 7Α-O-ia-dpn As an Single Photon Emission Computed Tomographic Imaging Agent for Mapping Opioid Receptors

18 F-Labeled PET Tracers Specific for Adenosine A 2A Receptor: Design, Synthesis, and Biological Evaluation

[18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans

Synthesis and pharmacological evaluation of [18F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971